TRPX - Therapix Biosciences Ltd.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
-0.0544 (-10.57%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.5146
Bid0.0000 x 900
Ask0.0000 x 1100
Day's Range0.4501 - 0.5290
52 Week Range0.4050 - 4.8000
Avg. Volume187,624
Market Cap3.323M
Beta (5Y Monthly)0.18
PE Ratio (TTM)N/A
EPS (TTM)-2.7980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • CNW Group

    SOL Global Portfolio Company Heavenly Rx, Ltd. Enters Into MOU for Business Combination with Therapix Biosciences

    TORONTO, Nov. 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCPK:SOLCF - News) (Frankfurt:9SB.F - News) announced today that its 40.7% owned portfolio company Heavenly  Rx, Ltd. ("Heavenly Rx") has entered into a memorandum of understanding ("MOU") with the US NASDAQ listed public company, Therapix Biosciences Ltd (NASDAQ:TRPX - News), a speciality clinical-stage pharmaceutical company with a portfolio of technologies and assets based on cannabinoid pharmaceuticals, pursuant to which Therapix and Heavenly Rx have agreed to pursue a business combination. Pursuant to the MOU, the parties will negotiate a definitive agreement for a business combination between Therapix and Heavenly Rx, constituting a reverse takeover of Therapix by Heavenly Rx.